The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 21st 2025
An oral dose of 0.6 mg per 5 ml of colchicine could aid individuals that have trouble with swallowing pills.
Phase 3 Data Favor Bimekizumab Over Placebo in Biologic-Naïve Patients With Psoriatic Arthritis
December 20th 2022All primary and ranked secondary endpoints of the study were met at week 16, which were sustained or improved through week 24 and were coupled with patient-reported improvements compared with placebo in treating psoriatic arthritis.
Read More
Study Results Suggest Exercise, Mindfulness Do Not Boost Cognitive Function in Older Adults
December 19th 2022Although physical activity and the practice of being present in the moment are associated with many benefits, analysis shows that neither led to measurable improvements in brain health.
Read More
Study Finds RAS Inhibition Has Little Effect on Outcomes in Advanced Chronic Kidney Disease
December 16th 2022A randomized study of renin-angiotensin system inhibitors in advanced chronic kidney disease found that patients who continued receiving therapy had similar outcomes to those who discontinued treatment.
Read More
FDA Approves Adalimumab Biosimilar for Plaque Psoriasis, Other Chronic Conditions
December 16th 2022Adalimumab-aacf (Idacio) is indicated for chronic conditions such as rheumatoid arthritis, plaque psoriasis, ulcerative colitis, psoriatic arthritis, hidradenitis suppurativa, and juvenile idiopathic arthritis.
Read More
Study Identifies Barriers to PrEP Uptake in Black Female Adolescents, Young Adults
December 16th 2022Study findings provide insight into factors preventing the uptake of pre-exposure prophylaxis for HIV among Black female adolescents and emerging adults and provide potential strategies to improve uptake.
Read More